139 related articles for article (PubMed ID: 22546381)
1. Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer.
Ramsey SD; Zeliadt SB; Blough DK; Fedorenko CR; Fairweather ME; McDermott CL; Penson DF; Van Den Eeden SK; Hamilton AS; Arora NK
Urology; 2012 May; 79(5):1034-41. PubMed ID: 22546381
[TBL] [Abstract][Full Text] [Related]
2. Complementary and alternative medicine use among newly diagnosed prostate cancer patients.
McDermott CL; Blough DK; Fedorenko CR; Arora NK; Zeliadt SB; Fairweather ME; Oakley-Girvan I; Van Den Eeden SK; Ramsey SD
Support Care Cancer; 2012 Jan; 20(1):65-73. PubMed ID: 21120540
[TBL] [Abstract][Full Text] [Related]
3. Patient-physician communication regarding use of complementary therapies during cancer treatment.
Roberts CS; Baker F; Hann D; Runfola J; Witt C; McDonald J; Livingston ML; Ruiterman J; Ampela R; Kaw OC; Blanchard C
J Psychosoc Oncol; 2005; 23(4):35-60. PubMed ID: 16618687
[TBL] [Abstract][Full Text] [Related]
4. Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors.
Jones RA; Taylor AG; Bourguignon C; Steeves R; Fraser G; Lippert M; Theodorescu D; Mathews H; Kilbridge KL
Oncol Nurs Forum; 2007 Mar; 34(2):359-64. PubMed ID: 17573300
[TBL] [Abstract][Full Text] [Related]
5. Use of complementary and alternative medicine among men with prostate cancer in a rural setting.
Butler S; Owen-Smith A; DiIorio C; Goodman M; Liff J; Steenland K
J Community Health; 2011 Dec; 36(6):1004-10. PubMed ID: 21499937
[TBL] [Abstract][Full Text] [Related]
6. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
[TBL] [Abstract][Full Text] [Related]
7. Frequent use of complementary medicine by prostate cancer patients.
Ponholzer A; Struhal G; Madersbacher S
Eur Urol; 2003 Jun; 43(6):604-8. PubMed ID: 12767359
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of the use of alternative therapies by men with localized prostate cancer.
Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
Patient Educ Couns; 2004 Oct; 55(1):70-7. PubMed ID: 15476992
[TBL] [Abstract][Full Text] [Related]
9. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
Barocas DA; Alvarez J; Resnick MJ; Koyama T; Hoffman KE; Tyson MD; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF
JAMA; 2017 Mar; 317(11):1126-1140. PubMed ID: 28324093
[TBL] [Abstract][Full Text] [Related]
10. Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.
Krahn M; Ritvo P; Irvine J; Tomlinson G; Bremner KE; Bezjak A; Trachtenberg J; Naglie G
Med Care; 2003 Jan; 41(1):153-64. PubMed ID: 12544552
[TBL] [Abstract][Full Text] [Related]
11. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.
Diefenbach MA; Hamrick N; Uzzo R; Pollack A; Horwitz E; Greenberg R; Engstrom PF
J Urol; 2003 Jul; 170(1):166-9. PubMed ID: 12796672
[TBL] [Abstract][Full Text] [Related]
12. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
Singh H; Maskarinec G; Shumay DM
Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
[TBL] [Abstract][Full Text] [Related]
13. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.
Boon H; Westlake K; Stewart M; Gray R; Fleshner N; Gavin A; Brown JB; Goel V
Urology; 2003 Nov; 62(5):849-53. PubMed ID: 14624907
[TBL] [Abstract][Full Text] [Related]
14. Patients' perceptions of quality of life after treatment for early prostate cancer.
Clark JA; Inui TS; Silliman RA; Bokhour BG; Krasnow SH; Robinson RA; Spaulding M; Talcott JA
J Clin Oncol; 2003 Oct; 21(20):3777-84. PubMed ID: 14551296
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study.
Yarney J; Donkor A; Opoku SY; Yarney L; Agyeman-Duah I; Abakah AC; Asampong E
BMC Complement Altern Med; 2013 Jan; 13():16. PubMed ID: 23331546
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with discontinuation of complementary and alternative medicine among Korean cancer patients.
Kim SY; Kim KS; Park JH; Shin JY; Kim SK; Park JH; Park EC; Seo HG
Asian Pac J Cancer Prev; 2013; 14(1):225-30. PubMed ID: 23534728
[TBL] [Abstract][Full Text] [Related]
17. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.
Chan JM; Elkin EP; Silva SJ; Broering JM; Latini DM; Carroll PR
Urology; 2005 Dec; 66(6):1223-8. PubMed ID: 16360447
[TBL] [Abstract][Full Text] [Related]
18. Changes in sexual functioning in women after neuromodulation for voiding dysfunction.
Yih JM; Killinger KA; Boura JA; Peters KM
J Sex Med; 2013 Oct; 10(10):2477-83. PubMed ID: 23445354
[TBL] [Abstract][Full Text] [Related]
19. Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan.
Yoshimura K; Ichioka K; Terada N; Terai A; Arai Y
Int J Clin Oncol; 2003 Feb; 8(1):26-30. PubMed ID: 12601539
[TBL] [Abstract][Full Text] [Related]
20. Complementary and alternative medicine use among cancer patients at the end of life: Korean national study.
Choi JY; Chang YJ; Hong YS; Heo DS; Kim S; Lee JL; Choi JS; Kang KM; Kim SY; Jeong HS; Lee CG; Choi YS; Lim HY; Yun YH
Asian Pac J Cancer Prev; 2012; 13(4):1419-24. PubMed ID: 22799342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
